Literature DB >> 29121248

Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica.

Claire E Owen1,2, Aurora M T Poon2,3, Sze Ting Lee2,3,4, Lee Pheng Yap5, Richard B Zwar5, Christine M McMenamin1, Simon K L Lam1, David F L Liew1,2, Kunthi Pathmaraj3, Andrew Kemp5, Andrew M Scott2,3,4, Russell R C Buchanan1,2.   

Abstract

Objectives: To characterize 18F-fluorodeoxyglucose (18F-FDG) uptake on whole-body PET/CT in PMR, and identify its precise anatomic correlate using MRI.
Methods: Patients with newly diagnosed PMR according to the 2012 EULAR/ACR classification criteria were prospectively recruited. Participants with GCA were excluded. A whole-body 18F-FDG PET/CT scan was performed in all untreated patients. Qualitative and semiquantitative [standardized uptake value maximum (SUVmax)] scoring of abnormal 18F-FDG uptake was undertaken. MRI of the pelvis, knee and wrist and hand was performed in three representative patients with anatomical correlation of FDG-avid sites carried out using Medview fusion software.
Results: Twenty-two patients with PMR were recruited. Their mean age was 68.3 years (s.d. 6.3) and 13/22 were male. On whole-body PET/CT, 18F-FDG uptake adjacent to the ischial tuberosities was observed in 21 participants (95.4%) and recorded the highest mean SUVmax value [3.6 (s.d. 1.7)]. A high frequency of posteromedial knee (61.9%) and wrist and/or hand involvement (66.7%) was also appreciated. MRI of the pelvis revealed high T2 signal surrounding the proximal hamstring tendon origins of both semimembranosus and the conjoint tendon of the semitendinosus and biceps femoris. At the knee, peritendonitis at the distal insertion of the semimembranosus was observed. PET/MRI fusion at the pelvis and knee confirmed semimembranosus peritendonitis as the anatomical correlate of 18F-FDG uptake adjacent to the ischial tuberosities and of posteromedial knee structures.
Conclusion: Hamstring peritendonitis is a common and distinctive manifestation of PMR on whole-body PET/CT. Trial registration: Australian New Zealand Clinical Trials Registry, http://www.anzctr.org.au, ACTRN1261400696695.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  hamstring; magnetic resonance imaging; peritendonitis; polymyalgia rheumatica; whole-body positron emission tomography/computed tomography

Mesh:

Substances:

Year:  2018        PMID: 29121248     DOI: 10.1093/rheumatology/kex411

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  3 in total

Review 1.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

2.  Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Abraham Rutgers; T Jeroen N Hiltermann; Sjoukje F Oosting; Riemer H J A Slart; Elisabeth Brouwer
Journal:  Ann Rheum Dis       Date:  2020-04-02       Impact factor: 27.973

3.  Ultrasound of shoulder and knee improves the accuracy of the 2012 EULAR/ACR provisional classification criteria for polymyalgia rheumatica.

Authors:  Kei Kobayashi; Daiki Nakagomi; Yoshiaki Kobayashi; Chisaki Ajima; Shunichiro Hanai; Kensuke Koyama; Kei Ikeda
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.